‘Something needs to change’: An Allergan analyst spells out why next week’s vote could...

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Apr 26, 2019 at 10:32 AM.

  1. #1 cafead, Apr 26, 2019 at 10:32 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,990
    Likes Received:
    3
    via Just because ISS and Glass Lewis have thrown their weight behind Allergan CEO Brent Saunders in the upcoming shareholder vote at the annual meeting on Wednesday doesn’t mean that die-hard critics have put aside the manifestoes and helmets in preparation for a proper melee.

    article source
     
    Quote

Reply to Thread